Mechanistically, ERβ phosphorylation and non-genomic signaling of S-equol in cytotoxic CD8+ effector T-cells (Teffs) boosted T-cell receptor activity and PD1 Ab-driven anti-tumor response. The gene discussed is PDCD1; the disease is neoplasm.